Dale R. Pfost - 14 Mar 2022 Form 4 Insider Report for Chemomab Therapeutics Ltd. (CMMB)

Role: Chief Executive Officer, Director
Signature: /s/ Matthew Rudolph, Attorney-in-Fact for Dale R. Pfost
Issuer symbol: CMMB
Transactions as of: 14 Mar 2022
Net transactions value: +$9,943
Form type: 4
Filing time: 15 Mar 2022, 16:10:10 UTC
Previous filing: 04 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMMB	American Depositary Shares	Purchase	$7,164	+1,800		$3.98	1,800	14 Mar 2022	Direct	F1
transaction	CMMB	American Depositary Shares	Purchase	$2,779	+700	+39%	$3.97	2,500	14 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMMB	Option to Purchase American Depositary Shares	Award	$0	+459,353		$0.000000	459,353	25 Oct 2021	American Depositary Shares	459,353	$10.05	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
F2	No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
F3	The options vest and become exercisable over a period of four (4) years with one quarter (1/4) of the options vesting on October 25, 2022 -- the first anniversary of the grant date -- and the remainder in equal amounts over the ensuing 36 monthly periods, subject to the Reporting Person's continued service.